Literature DB >> 20826462

Src-dependent phosphorylation of ROCK participates in regulation of focal adhesion dynamics.

Hsiao-Hui Lee1, Sui-Chih Tien, Tzuu-Shuh Jou, Yuan-Chen Chang, Jheng-Guang Jhong, Zee-Fen Chang.   

Abstract

When a cell migrates, the RhoA-ROCK-mediated contractile signal is suppressed in the leading edge to allow dynamic adhesions for protrusion. However, several studies have reported that RhoA is indeed active in the leading edge of a migrating cell during serum stimulation. Here, we present evidence that regulation of ROCKII phosphorylation at the Y722 site in peripheral focal contacts is crucial for controlling the turnover of the focal adhesion (FA) complex uncoupled from RhoA activation during serum-stimulated migration. However, this phosphorylation control is dispensable for migration when RhoA is downregulated in cells treated with platelet-derived growth factor (PDGF). We further present evidence that ROCKII is phosphorylated by Src in FAs and this phosphorylation event decreases RhoA binding activity of ROCKII. Lack of this regulatory control leads to sustained myosin-mediated contractility and FA elongation during lysophosphatidic acid (LPA) stimulation. Altogether, our data suggest that Src-dependent ROCKII phosphorylation provides a means of tuning contractility required for FAs dynamics when RhoA is active.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826462     DOI: 10.1242/jcs.071555

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  26 in total

1.  Kinase activity profiling of gram-negative pneumonia.

Authors:  Arie J Hoogendijk; Sander H Diks; Maikel P Peppelenbosch; Tom Van Der Poll; Catharina W Wieland
Journal:  Mol Med       Date:  2011-03-15       Impact factor: 6.354

Review 2.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 3.  Small Rho GTPases in the control of cell shape and mobility.

Authors:  Arun Murali; Krishnaraj Rajalingam
Journal:  Cell Mol Life Sci       Date:  2013-11-26       Impact factor: 9.261

Review 4.  Integrins and cadherins join forces to form adhesive networks.

Authors:  Gregory F Weber; Maureen A Bjerke; Douglas W DeSimone
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

5.  The Transcriptional Repressor ZNF503/Zeppo2 Promotes Mammary Epithelial Cell Proliferation and Enhances Cell Invasion.

Authors:  Payam Shahi; Euan M Slorach; Chih-Yang Wang; Jonathan Chou; Angela Lu; Aline Ruderisch; Zena Werb
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

Review 6.  The on-off relationship of Rho and Rac during integrin-mediated adhesion and cell migration.

Authors:  Campbell D Lawson; Keith Burridge
Journal:  Small GTPases       Date:  2014-03-07

Review 7.  Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy.

Authors:  Nicola Rath; Michael F Olson
Journal:  EMBO Rep       Date:  2012-09-11       Impact factor: 8.807

8.  Shp2 plays a crucial role in cell structural orientation and force polarity in response to matrix rigidity.

Authors:  Hsiao-Hui Lee; Hsin-Chang Lee; Chih-Chiang Chou; Sung Sik Hur; Katie Osterday; Juan C del Álamo; Juan C Lasheras; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.

Authors:  Zhongwen Chen; Dongmyung Oh; Kabir H Biswas; Cheng-Han Yu; Ronen Zaidel-Bar; Jay T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-04       Impact factor: 11.205

10.  PTK7-Src signaling at epithelial cell contacts mediates spatial organization of actomyosin and planar cell polarity.

Authors:  Anna Andreeva; Jianyi Lee; Madhura Lohia; Xiaoji Wu; Ian G Macara; Xiaowei Lu
Journal:  Dev Cell       Date:  2014-04-03       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.